The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHeiq Regulatory News (HEIQ)

Share Price Information for Heiq (HEIQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 13.05
Ask: 14.95
Change: 0.00 (0.00%)
Spread: 1.90 (14.559%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
HEIQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual General Meeting Update

21 Jun 2021 16:30

RNS Number : 6040C
HeiQ PLC
21 June 2021
 

21 June 2021

 

HeiQ Plc

("HeiQ" or "the Company")

 

Annual General Meeting Update

 

HeiQ Plc (LSE: HEIQ), an established global brand in materials and textile innovation which operates in high-growth markets, announces that following the UK Government announcement that the COVID-19 restrictions which were expected to be lifted on 21 June 2021 have been extended to 19 July 2021, in order to protect the health and safety of the Company's Shareholders and Directors and Advisers, the Company's Annual General Meeting to be held on 25 June 2021 (the "AGM") will be held as a fully closed meeting and there will be no ability for shareholders to attend the satellite meeting place in the UK.

 

As noted in the Company's announcement of 13 May 2021, and as stated in the notice of AGM, the meeting will be held at Ruetistrasse 12, 8952 Schlieren (Zurich), Switzerland and due to COVID-19 restrictions in place in Switzerland, no shareholders will be permitted to attend the AGM in person in Switzerland.

 

The quorum for the AGM will be arranged by the Company to ensure that the meeting is quorate. Other Shareholders and their proxies should not attempt to attend the AGM in person either at the location of the AGM or at the satellite meeting place as they will not be permitted to enter the venues.

 

Shareholders are therefore strongly encouraged to submit their votes by proxy in advance and to appoint the Chair of the AGM as their proxy. If a Shareholder appoints someone else as their proxy, that proxy will not be able to attend the meeting in order to cast the Shareholder's vote and that vote will not be counted.

 

The Directors consider the AGM to be an important part of the Company's shareholder engagement, and arrangements have been made for an electronic facility which enables shareholders to access the AGM remotely and follow the business of the AGM by Zoom. Shareholders are also encouraged to submit questions relating to the business of the meeting ahead of the AGM.

 

It is important to note that Shareholders viewing the AGM via the Zoom platform will not be formally in attendance at the AGM and will not be able to vote at the AGM via the electronic platform. Voting on the resolutions at the AGM will be taken on a poll to ensure that Shareholders' proxy votes received in advance are recognised. All of the votes of the Shareholders present will be counted, and added to those received by proxy, and the provisional voting figures will be displayed at the AGM and via the electronic platform. The final results of the voting on the resolutions will be announced shortly after the AGM via the Regulatory News Service and published on the Company's website.

 

Shareholders wishing to raise any questions relating to the business of the AGM may do so as noted below. The Company requests that questions be submitted by 5.00 p.m. BST on Wednesday 23 June 2021 and management will endeavour to answer as many pre-submitted questions on the call as possible. HeiQ will publish and maintain an appropriate summary of responses on its website after the AGM. To request access to view the AGM remotely and/or to submit a question please email corporatesecretary@heiq.com in line with the deadline outlined above.

 

For further information, please contact:

 

HeiQ Plc

Carlo Centonze (CEO)

+41 56 250 68 50

Arlington Group Asset Management Limited (Financial Advisor and Joint Broker)

Charles Cannon Brookes

+44 (0) 207 389 5017

Cenkos Securities plc (Joint Broker)

Stephen Keys / Callum Davidson

+44 (0) 207 397 8900

SEC Newgate (Media Enquiries)

Elisabeth Cowell / Robin Tozer / Megan Kovach

+44 (0) 20 3757 6882

HeiQ@secnewgate.co.uk

 

 

About HeiQ

HeiQ is focused on improving the lives of billions of people world-wide by innovating the materials people use every day. It is an IP-rich pioneer which is at the forefront of global technology in the $10 billion antimicrobial fabrics and $24 billion textile chemicals market. It has also moved into the medical device, healthcare and probiotics markets, to help make hospitals and healthcare environments more hygienic.

HeiQ has created some of the most effective, durable and high-performance technologies and textile effects in the market today, which cool, warm, dry, repel, purify, and destroy viruses. Since 2005, HeiQ has developed over 200 technologies in partnership with 300 major brands. It has won multiple awards and gained a strong reputation for sustainability.

Led by an experienced management team, HeiQ rapidly researches new solutions for partners, quickly delivers scaled up manufacturing from its sites across the world and helps partners market the product to end consumers - aiming for lab to consumer in months.

HeiQ aims to deliver growth for its shareholders through a combination of increased sales of its core products and by entering additional lucrative markets through disruptive innovations and M&A. It has a healthy R&D pipeline containing over 40 projects.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAZZGZVKMDGMZM
12
Date   Source Headline
28th Apr 20227:00 amRNSResults for the year ended 31 December 2021
14th Apr 20227:00 amRNSFY 2021 Trading Update and Notice of Results
24th Feb 20222:55 pmRNSIssue of Equity
17th Feb 20222:35 pmRNSDirector/PDMR Shareholding
14th Feb 20227:00 amRNSHUGO BOSS and LYCRA back new climate positive yarn
3rd Dec 20217:00 amRNSInvestor Presentation
28th Sep 20219:05 amRNSSecond Price Monitoring Extn
28th Sep 20219:00 amRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSInterim Results
20th Sep 20217:00 amRNSNotice of Results and Investor Presentation
16th Jul 20217:00 amRNSCollaboration Agreement with The LYCRA Company
9th Jul 20217:00 amRNSCompletion of Acquisition
28th Jun 20211:45 pmRNSFurther re. Annual General Meeting
25th Jun 20214:40 pmRNSResult of AGM
21st Jun 20214:30 pmRNSAnnual General Meeting Update
15th Jun 20217:00 amRNSAcquisition Life Material Technologies Limited
9th Jun 20217:00 amRNSHeiQ Chrisal water treatment solution contract win
28th May 20217:00 amRNSCreates sustainable textile finishing partnership
20th May 20214:20 pmRNSProgressive initiates coverage
13th May 20217:00 amRNSNotice of AGM
29th Apr 20217:00 amRNSAcquisition of RAS AG
28th Apr 20217:00 amRNSResults for the year ended December 31, 2020
8th Apr 20217:00 amRNSNotice of Results and Investor Presentation
19th Mar 20217:00 amRNSHeiQ Viroblock Agreement with ICP
11th Mar 20217:00 amRNSHeiQ Viroblock Partnership with Berger Paint
3rd Mar 20217:00 amRNSAcquisition of 51% of Industrial Biotech Business
11th Feb 20217:00 amRNSHeiQ Viroblock Contract Win
28th Jan 202111:30 amRNSLaunch of HeiQ Viroblock Permanent
27th Jan 20219:05 amRNSSecond Price Monitoring Extn
27th Jan 20219:00 amRNSPrice Monitoring Extension
26th Jan 20219:05 amRNSSecond Price Monitoring Extn
26th Jan 20219:00 amRNSPrice Monitoring Extension
26th Jan 20217:00 amRNSTrading Update
13th Jan 20217:00 amRNSChange of External Auditor
5th Jan 20212:01 pmRNSPrice Monitoring Extension
4th Jan 20219:05 amRNSSecond Price Monitoring Extn
4th Jan 20219:00 amRNSPrice Monitoring Extension
15th Dec 20207:00 amRNSMajority stake in medical device manufacturer
9th Dec 202011:15 amRNSDirector/PDMR Dealings
9th Dec 20207:00 amRNSInvestor Presentation
7th Dec 20208:00 amRNSAdmission to Trading and First Day of Dealings
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.